Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use LOKELMA® safely and effectively. See full prescribing information for LOKELMA®. LOKELMA® (sodium zirconium cyclosilicate) for oral suspension Initial U.S. Approval: 2018
Medication labelWhy this: Advisory · dailymed-prescription
LOKELMA is indicated for the treatment of hyperkalemia in adults. Limitation of Use LOKELMA should not be used as an emergency treatment for life-threatening hyperkalemia because of its delayed onset of action [see Clinical Pharmacology (12.2) and Clinical Studies (14)].
- generic_name
- sodium zirconium cyclosilicate
- product_names
- sodium zirconium cyclosilicate
- ndc
- 0310-1105, 0310-1105-01, 0310-1105-30, 0310-1105-39, 0310-1110, 0310-1110-01, 0310-1110-30, 0310-1110-91, 0310-1110-98, 0310-1110-39, 0310-1110-94, 0310-1110-93
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en